Status:
UNKNOWN
Vitamin A Supplementation in Children With Moderate to Severe COVID-19
Lead Sponsor:
Shiraz University of Medical Sciences
Conditions:
Covid19
Eligibility:
All Genders
1-18 years
Phase:
PHASE2
Brief Summary
Severe acute respiratory syndrome (SARS)-like coronavirus 2 (Sars-CoV-2) pandemia is considered to be the current major global health issue. With no specific treatment or vaccine known to be licensed,...
Eligibility Criteria
Inclusion
- 1\) aged between 1-month to 18-year old (boy or girl), 2) definitive or clinical diagnosis of severe acute respiratory syndrome (SARS)-like coronavirus 2 (SARS-COV-2) infection (by either a positive SARS-COV-2 polymerase chain reaction (PCR) test or a suggestive computed tomography (CT) scan, 3) no history or evidence of cancer or renal, hepatic, endocrine or viral disorders (including HIV/AIDS), 4) no history of supplementation either with vitamin A (VA) or with a multivitamin containing VA within the last 4 months, and 5) not participated in other clinical trials.
Exclusion
- 1\) mildly infected with SARS-COV-2 virus, and 2) pregnancy or lactation.
Key Trial Info
Start Date :
June 21 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 19 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04920760
Start Date
June 21 2021
End Date
December 19 2021
Last Update
June 18 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.